An Open-Label Rollover Study of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B Infection
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
To provide open-label entecavir to subjects who have completed previous blinded entecavir
trials in Japan and are assessed by the investigator as likely to benefit from additional
anti-hepatitis B therapy